The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

Pathologic Basis of Disease.

(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,593

Biologic basis for interleukin-1 in disease.

Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344

Hippocampal atrophy in recurrent major depression

Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V. L., Gillis, S. A., Henney, C. S., Kronheim, S. R., Grabstein, K. H., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,559

Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor

Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485

Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1

Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E. L., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,084

cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin Superfamily

Sims, J. E., March, C. J., Cosman, D. J., Widmer, M. B., MacDonald, H. R., McMahan, C. J., Grubin, C. E., Wignall, J. M., Jackson, J. L., Call, S. M., et al. (1988) · Science · doi:10.1126/science.2969618 · Cited by 877

A Meta-Analysis of Cytokines in Major Depression

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729

Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics

Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774

Stress and the inflammatory response: A review of neurogenic inflammation

Black, P. H. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00021-1 · Cited by 708

Research and treatment approaches to depression

Wong, M.-L., & Licinio, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072566 · Cited by 656

Major depression after breast cancer: a review of epidemiology and treatment

Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586

Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition

Wong, M.-L., Inserra, A., Lewis, M. D., Mastronardi, C. A., Leong, L., Choo, J., Kentish, S., Xie, P., Morrison, M., Wesselingh, S. L., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.46 · Cited by 568

Epidemiology of comorbid coronary artery disease and depression

Rudisch, B. E., & Nemeroff, C. B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00587-0 · Cited by 556

Cytokines as mediators of depression: what can we learn from animal studies?

Dunn, A. J., Swiergiel, A. H., & Beaurepaire, R. D. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.023 · Cited by 459

Assessing African medicinal plants for efficacy and safety: pharmacological screening and toxicology

Fennell, C. W., Lindsey, K. L., McGaw, L. J., Sparg, S. G., Stafford, G. I., Elgorashi, E. E., Grace, O. M., & van Staden, J. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.05.012 · Cited by 457

Leukocyte Telomere Length in Major Depression: Correlations with Chronicity, Inflammation and Oxidative Stress - Preliminary Findings

Wolkowitz, O. M., Mellon, S. H., Epel, E. S., Lin, J., Dhabhar, F. S., Su, Y., Reus, V. I., Rosser, R., Burke, H. M., Kupferman, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017837 · Cited by 421

Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis

Kuo, H., Yen, C., Chang, C., Kuo, C.-K., Chen, J.-H., & Sorond, F. A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70099-5 · Cited by 409

Role of Interleukin-6 in Depressive Disorder

Ting, E. Y.-C., Yang, A. C., & Tsai, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062194 · Cited by 404

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

Myint, A.-M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 387

Effects of antidepressants on the production of cytokines

Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370

Prenatal Depression, Prenatal Anxiety, and Spontaneous Preterm Birth: A Prospective Cohort Study Among Women With Early and Regular Care

Dayan, J., Creveuil, C., Marks, M. N., Conroy, S., Herlicoviez, M., Dreyfus, M., & Tordjman, S. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000244025.20549.bd · Cited by 356

Neuroplasticity and cellular resilience in mood disorders

Manji, H. K., Moore, G. J., Rajkowska, G., & Chen, G. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000811 · Cited by 340

Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy

Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., et al. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/76396 · Cited by 315

Depression and Other Mental Health Diagnoses Increase Mortality Risk After Ischemic Stroke

Williams, L. S., Ghose, S. S., & Swindle, R. W. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1090 · Cited by 309

Increased Serum Levels of 8-Hydroxy-2′-Deoxyguanosine in Clinical Depression

Forlenza, M. J., & Miller, G. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000195780.37277.2a · Cited by 309

Depression gets old fast: do stress and depression accelerate cell aging?

Wolkowitz, O. M., Epel, E. S., Reus, V. I., & Mellon, S. H. (2010) · Depression and Anxiety · doi:10.1002/da.20686 · Cited by 298

Selected biomarkers of depression: what are the effects of cytokines and inflammation

Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299

Interleukin 18 in the CNS

Alboni, S., Cervia, D., Sugama, S., & Conti, B. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-9 · Cited by 306

Depression in patients with chronic renal disease

Kimmel, P. L. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00310-0 · Cited by 297

Polymorphisms in Inflammation-Related Genes Are Associated with Susceptibility to Major Depression and Antidepressant Response

Wong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295

Antidepressant activity of aqueous extracts of Curcuma longa in mice

Yu, Z. F., Kong, L., & Chen, Y. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00211-8 · Cited by 296

The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines

Spalletta, G., Bossù, P., Ciaramella, A., Bria, P., Caltagirone, C., & Robinson, R. G. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001879 · Cited by 301

Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines

Kunz-Ebrecht, S., Mohamed‐Ali, V., Feldman, P. J., Kirschbaum, C., & Steptoe, A. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00029-1 · Cited by 295

Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?

McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653377 · Cited by 277

Inflammatory T helper 17 cells promote depression-like behavior in mice

Beurel, E., Harrington, L. E., & Jope, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.021 · Cited by 254

Inflammation in Children and Adolescents With Neuropsychiatric Disorders: A Systematic Review

Mitchell, R. H. B., & Goldstein, B. I. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.013 · Cited by 247

The Molecular Neurobiology of Depression

Shelton, R. C. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.12.005 · Cited by 244

Plasma and Cerebrospinal Fluid Interleukin-6 Concentrations in Posttraumatic Stress Disorder

Baker, D. G., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Zoumakis, E., Dashevsky, B. A., Chrousos, G. P., & Geracioti Jr., T. D. (2001) · Neuroimmunomodulation · doi:10.1159/000049028 · Cited by 238

Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: Identification of subgroups with immune responses and blood–CSF barrier dysfunction

Bechter, K., Reiber, H., Herzog, S., Fuchs, D., Tumani, H., & Maxeiner, H. G. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.008 · Cited by 235

Anti-inflammatory properties of desipramine and fluoxetine

Roumestan, C., Michel, A., Bichon, F., Portet, K., Detoc, M., Henriquet, C., Jaffuel, D., & Mathieu, M. N. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-35 · Cited by 234

Screening, Diagnosis, and Treatment of Depression in Patients with End-Stage Renal Disease

Cohen, S. D., Norris, L., Acquaviva, K., Peterson, R. A., & Kimmel, P. L. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03951106 · Cited by 235

Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems

Gądek-Michalska, A., Tadeusz, J., Rachwalska, P., & Bugajski, J. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71527-5 · Cited by 225

From monoamines to genomic targets: a paradigm shift for drug discovery in depression

Wong, M., & Licinio, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1303 · Cited by 233

Social factors and individual vulnerability to chronic stress exposure

Bartolomucci, A., Palanza, P., Sacerdote, P., Panerai, A. E., Sgoifo, A., Dantzer, R., & Parmigiani, S. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.06.009 · Cited by 233

The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.

Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001084 · Cited by 224

Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders

Basso, A. M., Bratcher, N. A., Harris, R. R., Jarvis, M. F., Decker, M. W., & Rueter, L. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.018 · Cited by 224

Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells

Liu, D., Wang, Z., Liu, S., Wang, F., Zhao, S., & Hao, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.033 · Cited by 221

Faecalibacterium prausnitzii (ATCC 27766) has preventive and therapeutic effects on chronic unpredictable mild stress-induced depression-like and anxiety-like behavior in rats

Hao, Z., Wang, W., Guo, R., & Liu, H. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.02.025 · Cited by 242

Serotonin Regulates Osteoclast Differentiation Through Its Transporter

Battaglino, R. A., Fu, J., Späte, U., Ersoy, U., Joe, M., Sedaghat, L., & Stashenko, P. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040606 · Cited by 219

Depression and anxiety and outcomes of coronary artery bypass surgery

Pignay-Demaria, V., Lespérance, F., Demaria, R., Frasure‐Smith, N., & Perrault, L. P. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04391-6 · Cited by 214

Depressive disorders—is it time to endorse different pathophysiologies?

Antonijevic, I. A. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.04.004 · Cited by 215

Neuropsychiatric Disease and Toxoplasma gondii Infection

Henriquez, S., Brett, R. R., Alexander, J. K., Pratt, J. A., & Roberts, C. W. (2009) · NeuroImmunoModulation · doi:10.1159/000180267 · Cited by 217

Antioxidative enzymes and increased oxidative stress in depressive women

Kodydková, J., Vávrová, L., Zeman, M., Jirák, R., Macášek, J., Staňková, B., Tvrzická, E., & Žák, A. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.06.006 · Cited by 197

Th2 Cytokine Response in Major Depressive Disorder Patients before Treatment

Pavón, L., Sandoval-López, G., Eugenia Hernández, M., Loría, F., Estrada, I., Pérez, M., Moreno, J., Ávila, U., Leff, P., Antón, B., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.08.014 · Cited by 187

Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

Kunz, M., Ceresér, K. M. M., Goi, P. D., Fries, G. R., Teixeira, A. L., Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer‐Sant’Anna, M., Kapczinski, F. P., & Gama, C. S. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000300010 · Cited by 189

Cytokine and growth factor involvement in schizophrenia—support for the developmental model

Nawa, H., Takahashi, M., & Patterson, P. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000730 · Cited by 189

Minireview: Neuro-Immuno-Endocrine Modulation of the Hypothalamic-Pituitary-Adrenal (HPA) Axis by gp130 Signaling Molecules

Chesnokova, V., & Melmed, S. K. (2002) · Endocrinology · doi:10.1210/endo.143.5.8861 · Cited by 188

Assessment of a Multi-Assay, Serum-Based Biological Diagnostic Test for Major Depressive Disorder: A Pilot and Replication Study

Papakostas, G. I., Shelton, R. C., Kinrys, G., Henry, M. E., Bakow, B. R., Lipkin, S. H., Pi, B., Thurmond, L., & Bilello, J. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.166 · Cited by 180

Pharmacogenetics of antidepressant response

Porcelli, S., Drago, A., Fabbri, C., Gibiino, S., Calati, R., & Serretti, A. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100059 · Cited by 183

Constant Darkness Induces IL-6-Dependent Depression-Like Behavior through the NF- B Signaling Pathway

Monje, F. J., Cabatic, M., Divisch, I., Kim, E.-J., Herkner, K. R., Binder, B. R., & Pollak, D. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1537-11.2011 · Cited by 178

Cytokines, stress, and depressive illness

Anisman, H., & Merali, Z. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00009-0 · Cited by 225

Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines

Nawa, H., & Takei, N. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.06.002 · Cited by 179

Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer

Sephton, S. E., Dhabhar, F. S., Keuroghlian, A. S., Giese-Davis, J., McEwen, B. S., Ionan, A. C., & Spiegel, D. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.007 · Cited by 170

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans

Licinio, J., O'Kirwan, F., Irizarry, K. J. L., Merriman, B., Thakur, S., Jepson, R., Lake, S. L., Tantisira, K. G., Weiss, S. T., & Wong, M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001587 · Cited by 173

Depression: a major, unrecognized risk factor for osteoporosis?

Cizza, G., Ravn, P., Chrousos, G. P., & Gold, P. W. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00407-6 · Cited by 170

Expression of toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder

Kéri, S., Szabó, C., & Kelemen, O. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.03.020 · Cited by 165

Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts

Okusaga, O., Yolken, R. H., Langenberg, P., Lapidus, M., Arling, T. A., Dickerson, F. B., Scrandis, D. A., Severance, E., Cabassa, J. A., Balis, T., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.029 · Cited by 163

Depression in End-Stage Renal Disease Patients: A Critical Review

Kimmel, P. L., Cukor, D., Cohen, S. D., & Peterson, R. A. (2007) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2007.07.007 · Cited by 164

Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia

De La Garza, R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.016 · Cited by 153

Association Study of the Interleukin-1beta (C-511T) Genetic Polymorphism with Major Depressive Disorder, Associated Symptomatology, and Antidepressant Response

Yu, Y. W. ‐., Chen, T., Hong, C., Chen, H.-M., & Tsai, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300172 · Cited by 150

The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder

Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150

Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients

Futamura, T., Toyooka, K., Iritani, S., Niizato, K., Nakamura, R., Tsuchiya, K., Someya, T., Kakita, A., Takahashi, H., & Nawa, H. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001081 · Cited by 146

Updating the mild encephalitis hypothesis of schizophrenia

Bechter, K. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.019 · Cited by 146

Association of Anhedonia With Recurrent Major Adverse Cardiac Events and Mortality 1 Year After Acute Coronary Syndrome

Davidson, K. W., Burg, M. M., Kronish, I. M., Shimbo, D., Dettenborn, L., Mehran, R., Vorchheimer, D. A., Clemow, L., Schwartz, J. E., & Rieckmann, N. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.36 · Cited by 141

Depression and osteoporosis: epidemiology and potential mediating pathways

Mezuk, B., Eaton, W. W., & Golden, S. H. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0449-2 · Cited by 134

Brain-immune interactions and disease susceptibility

Marques-Deak, A., Cizza, G., & Sternberg, E. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001643 · Cited by 134

Nutrition, Inflammation, and Cognitive Function

Wärnberǵ, J., Gómez‐Martínez, S., Romeo, J., Díaz, L. E., & Marcos, A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03985.x · Cited by 128

Antidepressants Attenuate Increased Susceptibility to Colitis in a Murine Model of Depression

Varghese, A. K., Verdu, E. F., Berčík, P., Khan, W. I., Blennerhassett, P. A., Szechtman, H., & Collins, S. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.007 · Cited by 130

Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging

Duda, P., Wiśniewski, J., Wójtowicz, T., Wójcicka, O., Jaskiewicz, M. R., Drulis‐Fajdasz, D., Rakus, D., McCubrey, J. A., & Gizak, A. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1526925 · Cited by 123

Distinguishing fatigue and depression in patients with cancer.

Jacobsen, P. B., Donovan, K. A., & Weitzner, M. A. (2003) · PubMed · doi:10.1016/s1084-3612(03)00049-2 · Cited by 123

Green tea consumption is associated with depressive symptoms in the elderly

Niu, K., Hozawa, A., Kuriyama, S., Ebihara, S., Guo, H., Nakaya, N., Ohmori‐Matsuda, K., Takahashi, H., Masamune, Y., Asada, M., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28216 · Cited by 118

Cytokines and the aging brain – what we don't know might help us

Bodles, A. M., & Barger, S. W. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.07.011 · Cited by 122

Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1β and tumor necrosis factor-α

Loftis, J. M., Huckans, M. S., Ruimy, S., Hinrichs, D. J., & Hauser, P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.001 · Cited by 117

Major Depression Is a Risk Factor for Low Bone Mineral Density: A Meta-Analysis

Yirmiya, R., & Bab, I. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.016 · Cited by 117

Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changes

Anisman, H., Kokkinidis, L., & Merali, Z. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00011-9 · Cited by 112

Allopregnanolone as a mediator of affective switching in reproductive mood disorders

Schiller, C. E., Schmidt, P. J., & Rubinow, D. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3599-x · Cited by 113

Anti-TNF-α Compounds as a Treatment for Depression

Uzzan, S., & Azab, A. N. (2021) · Molecules · doi:10.3390/molecules26082368 · Cited by 112

Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression

Brunello, N., Alboni, S., Capone, G., Benatti, C., Blom, J. M. C., Tascedda, F., Kriwin, P., & Mendlewicz, J. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00004 · Cited by 104

The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder

Dubey, N., Hoffman, J. F., Schuebel, K., Yuan, Q., Martinez, P. E., Nieman, L. K., Rubinow, D. R., Schmidt, P. J., & Goldman, D. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.229 · Cited by 104

The role of the cytokine network in psychological stress

Kim, Y., & Maes, M. H. J. (2003) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2003.00026.x · Cited by 103

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis

Steenblock, C., Todorov, V., Kanczkowski, W., Eisenhofer, G., Schedl, A., Wong, M., Licinio, J., Bauer, M., Young, A. H., Gainetdinov, R. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0758-9 · Cited by 106

Untitled work

Streit (2005) · doi:10.1179/016164105x49463 · Cited by 100

Regulatory role of the cannabinoid CB2receptor in stress‐induced neuroinflammation in mice

Zoppi, S., Madrigal, J. L. M., Caso, J. R., García‐Gutiérrez, M. S., Manzanares, J., Leza, J. C., & García‐Bueno, B. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12607 · Cited by 99

Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong)

Wong, S. Y. S., Lau, E. M. C., Lynn, H., Leung, P., Woo, J., Cummings, S., & ORWOLL, E. S. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1730-2 · Cited by 98

The Association between Conventional Antidepressants and the Metabolic Syndrome

McIntyre, R. S., Park, K. Y., Law, C. W. Y., Sultan, F., Adams, A., Lourenço, M. T. C., Lo, A., Soczynska, J. K., Woldeyohannes, H. O., Alsuwaidan, M. T., et al. (2010) · CNS Drugs · doi:10.2165/11533280-000000000-00000 · Cited by 98

Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma

Inserra, A., Mastronardi, C. A., Rogers, G. B., Licinio, J., & Wong, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1359-3 · Cited by 99

REVIEW: Biological risk factors for late life depression

Tiemeier, H. W. (2003) · European Journal of Epidemiology · doi:10.1023/a:1025388203548 · Cited by 95

Depression and Stroke: Cause or Consequence?

Williams, L. S. (2005) · Seminars in Neurology · doi:10.1055/s-2005-923534 · Cited by 95

Chronic psychosocial stress down-regulates central cytokines mRNA

Bartolomucci, A., Palanza, P., Parmigiani, S., Pederzani, T., Merlot, É., Neveu, P. J., & Dantzer, R. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.09.009 · Cited by 95

Weight change and appetite disturbance as symptoms of adolescent depression: Toward an integrative biopsychosocial model

Maxwell, M. A., & Cole, D. A. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.007 · Cited by 99

Manipulation of dorsal raphe serotonergic neurons modulates active coping to inescapable stress and anxiety-related behaviors in mice and rats

Nishitani, N., Nagayasu, K., Asaoka, N., Yamashiro, M., Andoh, C., Nagai, Y., Kinoshita, H., Kawai, H., Shibui, N., Liu, B., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0254-y · Cited by 92

Plasma Concentrations of Interleukin-1β, Interleukin-6, Soluble Interleukin-2 Receptor and Tumor Necrosis Factor α of Depressed Patients in Japan

Kagaya, A., Kugaya, A., Takebayashi, M., Fukue, M., Saeki, T., Yamawaki, S., & Uchitomi, Y. (2001) · Neuropsychobiology · doi:10.1159/000054867 · Cited by 92

A multi‐component assessment model for monitoring training distress among athletes

Main, L. C., & Grove, B. (2009) · European Journal of Sport Science · doi:10.1080/17461390902818260 · Cited by 90

Autocrine Interleukin-10 Mediates Glucagon-Like Peptide-1 Receptor-Induced Spinal Microglial β-Endorphin Expression

Wu, H., Tang, X.-Q., Mao, X.-F., & Wang, Y. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1799-17.2017 · Cited by 87

Role of IL-1 in Poststroke Depressive-like Behavior in Mice

Craft, T. K. S., & DeVries, A. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.011 · Cited by 88

Common Genetic Contributions to Depressive Symptoms and Inflammatory Markers in Middle-Aged Men: The Twins Heart Study

Su, S., Miller, A. H., Snieder, H., Bremner, J. D., Ritchie, J., Maisano, C., Jones, L. R., Murrah, N. V., Goldberg, J. H., & Vaccarino, V. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31819082ef · Cited by 87

PERSPECTIVE

Licinio, J., & Wong, M.-L. (2014)

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848

Review: the role of inflammation in depression.

Patel, A. J. (2013) · PubMed · Cited by 96

Depression: an inflammatory illness?: Figure 1

Krishnadas, R., & Cavanagh, J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301779 · Cited by 392

Inflammatory mechanisms in major depressive disorder

Raedler, T. J. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32834b9db6 · Cited by 213